.jpg)
.png)
Last Updated: Tuesday, 22-Nov-2016 17:15:00 EST
As part of the recent launch of the RADAR Campaign (RADAR: RAre Disease AwaReness), the Foundation of the National Lipid Association has released a digital cookbook featuring recipes geared toward the patient with Familial Chylomicronemia Syndrome (FCS). The recipes included in the cookbook are low- to no-fat options offering a variety of healthy alternatives that are tasty and flavorsome! In addition to the cookbook, tearsheets and other patient resources were created to help improve the identification and management of rare lipid disorders.
Last Updated: Tuesday, 01-Nov-2016 18:30:00 EDT
The National Lipid Association is proud to announce the first-ever NLA Junior Faculty Research Award. The purpose of the award is to encourage scholarly advancement of Junior Faculty in the pursuit of a career related to hyperlipidemia and other lipid disorders in humans.
The award will be funded for three years, with two award cycles: Basic Science Award and Clinical Science Award.
Last Updated: Wednesday, 19-Oct-2016 13:30:00 EDT
Order Dyslipidemia GUIDELINES Pocket Card Part 1 and Part 2. Pocket cards include: Key Points, Lifestyle, General Management, Risk Assessment, Treatment Recommendations, Hypercholesterolemia, Algorithms, Charts, and Tables on Risk Calculators, Criteria for Classification for ASCVD, and more. Choose between print or digital download.
Last Updated: Monday, 03-Oct-2016 14:00:00 EDT
The new ICD-10 Codes released by the Center for Medicare & Medicaid Services (CMS) are now in effect. The codes became effective October 1, 2016. The two new specific codes for FH are:
- E78.01: Familial hypercholesterolemia
- Z83.42: Family history of familial hypercholesterolemia
The National Lipid Association (NLA) in collaboration with the FH Foundation submitted a proposal to the ICD-10 Coordination and Maintenance Committee to create new, specific ICD-10 codes for FH in January 2014.
Last Updated: Monday, 19-Sep-2016 14:15:00 EDT
This year, Familial Hypercholesterolemia (FH) Awareness Day is on September 24, 2016. It was initiated by The FH Foundation as part of their mission to raise awareness of FH in the public.
The National Lipid Association and the Foundation are thankful once again for another successful year of meetings and fundraising. But we still have much work to do.
Article By:
ANNE C. GOLDBERG, MD, FNLA
President, Foundation of the National Lipid Association
Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Diplomate, American Board of Clinical Lipidology
Some patients refuse statin therapy or cannot tolerate its side effects. Many of these patients seek alternative therapies, including red yeast rice (RYR), a widely available herbal supplement made by culturing a yeast, Monascus purpureus, on rice. This process produces 14 monacolins, compounds that inhibit HMG- CoA reductase, the rate-limiting step in hepatic cholesterol synthesis.1 One of the monacolins produced is monacolin K, which is chemically identical to lovastatin.
Article By:
RAM Y. GORDON, MD
Cardiac Specialists
Yale-New Haven Health System
Fairfield, CT
Diplomate, American Board of Clinical Lipidology
DAVID J. BECKER, MD
Division of Cardiology
Temple University Hospital
Philadelphia, PA
Pediatric hypertriglyceridemia (fasting triglycerides ≥ 130 mg/dL) was identified by routine screening in a healthy 14-year-old male. He was subsequently referred to our pediatric lipid clinic for evaluation. A fasting lipid profile confirmed hypertriglyceridemia: total cholesterol (TC): 136 mg/dL, triglyceride (TG): 357 mg/dL, low-density lipoprotein cholesterol (LDL-C): 18 mg/dL, high-density lipoprotein cholesterol (HDL-C): 47 mg/dL, and non-HDL-C: 89 mg/dL.
Article By:
JAMES J. MACIEJKO, MS, PhD, FACC
Director, Adult and Pediatric Lipid Clinics
St. John Hospital and Medical Center
Professor, Department of Internal Medicine
Wayne State University School of Medicine
Detroit, MI
PREMCHAND ANNE, MD, MPH, FACC
Pediatric and Adult Congenital Cardiology
St. John Providence Children’s Hospital
Clinical Assistant Professor, Department of Pediatrics
Wayne State University School of Medicine
Detroit, MI
MANISHA RAVI
University of Michigan
Ann Arbor, MI
Perceptions of Fish Oil Dietary Supplements (FODS)
Article By:
R. PRESTON MASON, PhD
Department of Medicine, Cardiovascular Division
Brigham and Women’s Hospital
Harvard Medicine School
Boston, MA
Elucida Research LLC
Beverly, MA
DANIEL E. HILLEMAN, PharmD
Creighton University School of Pharmacy and Health Professions
Omaha, NE
Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant disorder of lipid metabolism considered by international guidelines to be a genetically defined cause of familial hypercholesterolemia (FH).1–3 FDB arises from mutations in apolipoprotein B (apoB) affecting the affinity of apoB-containing low-density lipoprotein particles for the low-density lipoprotein receptor (LDL-R) and, subsequently, their rate of endocytosis and catabolism in hepatocytes.4 FDB i
Article By:
ROLF L. ANDERSEN, MD, FACC, FNLA
Director
Preventive Cardiology and Apheresis Clinic
Lancaster General Health/Penn Medicine
Lancaster, PA
Diplomate, American Board of Clinical Lipidology
LARS ANDERSEN, BA
Research Assistant
Lancaster General Health/Penn Medicine
Lancaster, PA